JP2021533801A5 - - Google Patents

Info

Publication number
JP2021533801A5
JP2021533801A5 JP2021509904A JP2021509904A JP2021533801A5 JP 2021533801 A5 JP2021533801 A5 JP 2021533801A5 JP 2021509904 A JP2021509904 A JP 2021509904A JP 2021509904 A JP2021509904 A JP 2021509904A JP 2021533801 A5 JP2021533801 A5 JP 2021533801A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
recombinant nucleic
vector
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021509904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021533801A (ja
JP7285022B2 (ja
Filing date
Publication date
Priority claimed from CN201810968173.0A external-priority patent/CN110857440B/zh
Application filed filed Critical
Publication of JP2021533801A publication Critical patent/JP2021533801A/ja
Publication of JP2021533801A5 publication Critical patent/JP2021533801A5/ja
Application granted granted Critical
Publication of JP7285022B2 publication Critical patent/JP7285022B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021509904A 2018-08-23 2019-08-23 組換えヒトII型ミトコンドリアダイニン様GTPaseの遺伝子配列及びその使用 Active JP7285022B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810968173.0A CN110857440B (zh) 2018-08-23 2018-08-23 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用
CN201810968173.0 2018-08-23
PCT/CN2019/102352 WO2020038473A1 (zh) 2018-08-23 2019-08-23 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用

Publications (3)

Publication Number Publication Date
JP2021533801A JP2021533801A (ja) 2021-12-09
JP2021533801A5 true JP2021533801A5 (https=) 2022-08-31
JP7285022B2 JP7285022B2 (ja) 2023-06-01

Family

ID=69592310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021509904A Active JP7285022B2 (ja) 2018-08-23 2019-08-23 組換えヒトII型ミトコンドリアダイニン様GTPaseの遺伝子配列及びその使用

Country Status (11)

Country Link
US (1) US11459584B2 (https=)
EP (1) EP3851535A4 (https=)
JP (1) JP7285022B2 (https=)
KR (1) KR102612148B1 (https=)
CN (1) CN110857440B (https=)
AU (1) AU2019323501B2 (https=)
BR (1) BR112021002566A2 (https=)
CA (1) CA3110153A1 (https=)
MX (1) MX2021002135A (https=)
SG (1) SG11202101236WA (https=)
WO (1) WO2020038473A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110857440B (zh) 2018-08-23 2021-02-19 武汉纽福斯生物科技有限公司 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用
CN111849998A (zh) * 2020-07-29 2020-10-30 武汉纽福斯生物科技有限公司 编码人卵黄状黄斑病蛋白1的核酸分子及其应用
CN117904156A (zh) * 2022-10-17 2024-04-19 武汉纽福斯生物科技有限公司 人线粒体动力蛋白样gtp酶及应用
WO2024226729A2 (en) * 2023-04-26 2024-10-31 Astellas Gene Therapies, Inc. Compositions and methods for opa1 gene therapy
CN117304293B (zh) * 2023-10-07 2025-08-08 浙江大学 一种鸡opa1抗原决定簇及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
WO1991018088A1 (en) 1990-05-23 1991-11-28 The United States Of America, Represented By The Secretary, United States Department Of Commerce Adeno-associated virus (aav)-based eucaryotic vectors
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
CA2379166C (en) 1999-08-09 2013-03-26 Targeted Genetics Corporation Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs
EP1771571A2 (en) 2004-07-30 2007-04-11 Targeted Genetics Corporation Recombinant aav based vaccine methods
PT1880008E (pt) * 2005-05-03 2015-08-27 Inserm Inst Nat De La Santé Et De La Rech Médicale Expressão de proteína mitocondrial através de uma abordagem alotópica melhorada
WO2007134818A2 (en) * 2006-05-18 2007-11-29 Univ Muenchen L Maximilians Method for diagnosing mitochondrial dysfunction
CN102634527B (zh) * 2012-04-11 2013-11-06 华中科技大学同济医学院附属同济医院 重组人nadh脱氢酶亚单位4基因及其表达载体构建方法
AU2013293270B2 (en) * 2012-07-25 2018-08-16 Massachusetts Institute Of Technology Inducible DNA binding proteins and genome perturbation tools and applications thereof
AR095983A1 (es) * 2013-04-03 2015-11-25 Aliophtha Ag Factores artificiales de transcripción para el tratamiento de enfermedades causadas por haploinsuficiencia de opa1
CN104450747B (zh) * 2014-09-23 2018-02-09 武汉纽福斯生物科技有限公司 用于治疗Leber遗传性视神经病变的重组腺相关病毒‑NADH脱氢酶亚单位4基因全长以及药剂
EP3289080B1 (en) * 2015-04-30 2021-08-25 The Trustees of Columbia University in the City of New York Gene therapy for autosomal dominant diseases
WO2017191274A2 (en) 2016-05-04 2017-11-09 Curevac Ag Rna encoding a therapeutic protein
EP3548039B1 (en) * 2016-12-04 2023-07-19 Alavi Khorassani Moghadam, Marcel Victor Ribavirin for use in the treatment of a mitochondrial disease
WO2018146588A1 (en) 2017-02-08 2018-08-16 Friedrich Miescher Institute For Biomedical Research Synp88, a promoter for the specific expression of genes in retinal ganglion cells
CN111068071A (zh) * 2018-10-22 2020-04-28 武汉纽福斯生物科技有限公司 基因治疗Leber遗传学视神经病变
CN110857440B (zh) 2018-08-23 2021-02-19 武汉纽福斯生物科技有限公司 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用

Similar Documents

Publication Publication Date Title
JP2021533801A5 (https=)
US11542525B2 (en) Recombinant AAV variants and uses thereof
JP7592332B2 (ja) 横隔膜特異的核酸調節エレメントならびにその方法および使用
JP7577291B2 (ja) Aavカプシド設計
CN112040988A (zh) 修饰的aav衣壳多肽用于治疗肌肉疾病
US20200316221A1 (en) Aav capsid designs
TW201629225A (zh) 第九因子基因療法
CN116440292A (zh) Danon病和其它自噬障碍的治疗方法
JP2022524434A (ja) Fviii治療薬を発現するための非ウイルス性dnaベクターおよびその使用
WO2023006890A1 (en) Improving the efficacy of muscle-targeted gene therapy
CN113195719A (zh) 用于增加蛋白质表达和/或治疗单倍剂量不足症的方法及组合物
JP2019524090A5 (https=)
KR20250105716A (ko) 간에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법
US20200024323A1 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
WO2023202469A1 (zh) 一种用于遗传性凝血因子缺乏病治疗的核酸构建体及其用途
ES2773305T3 (es) Composición para la prevención o tratamiento de la esclerosis lateral amiotrófica que utiliza dos o más isoformas del factor de crecimiento de hepatocitos
JP2024529170A (ja) 治療薬の逆行性冠状静脈又は洞投与
JP2024527742A5 (https=)
JP2024502044A (ja) センス・サプレッサートランスファーrna組成物ならびに関連する用途及び機能
WO2024079661A1 (en) Atp7b gene therapy
JP2025523952A (ja) 筋肉特異的調節カセット
TW202337476A (zh) 用於與肌肉萎縮蛋白有關之心肌病之基因療法組合物及治療
JP2024528997A (ja) 放射線誘発性唾液機能低下を予防するためのaqp1遺伝子療法
US20260124322A1 (en) Atp7b gene therapy
WO2024257061A1 (en) A hybrid dual aav vector system with splice enhancer elements for expression of large genes